BLOG / 🇮🇳 India / ma activity · · daily

India Merger Acquisition MCA Regulatory Filings — September 18, 2026

India MCA Merger & Acquisition Tracker

By Gunpowder Editorial ·

8 high priority 3 medium priority 11 total filings analysed

Executive Summary

The September 18, 2026, MCA Merger & Acquisition Tracker reveals a market bifurcated between high-value strategic acquisitions and low-materiality corporate housekeeping. The most significant development is Gujarat Themis Biosyn's ₹1,220+ crore acquisition of MicroBiopharm Japan, a highly accretive, debt-funded deal that expands fermentation capabilities and global footprint but introduces leverage risk.

Sky Gold & Diamonds' ₹9 crore acquisition of Purvi Gems is a standout, with the target showing a stellar 30% YoY revenue growth (₹103.4 Cr in FY26 vs ₹78.95 Cr in FY25), making it a high-value bolt-on at a reasonable valuation. Conversely, several filings are low-impact incorporations (Indoco, Welspun, Ashika) or routine asset purchases (Oneindig). A key portfolio-level trend is the prevalence of cash-funded, non-related party transactions, suggesting disciplined capital allocation. The lone insider activity signal—a promoter buying shares in Meghna Infracon at ₹687.99—is a minor positive but lacks materiality. Overall, the tracker signals a cautious but opportunistic M&A environment, with growth capital flowing to high-margin, scalable sectors like specialty pharma and branded jewellery.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: M&A

Tracking the trend? Catch up on the prior India Merger Acquisition MCA Regulatory Filings digest from September 10, 2026.

Investment Signals (10)

  • Gujarat Themis Biosyn ↓ (BULLISH)
    ▲

    Acquired 100% of MicroBiopharm Japan for JPY 21.5B (₹1,220+ Cr). MBJ generated JPY 9.5B in FY26 revenue, implying a ~2.3x revenue multiple. The deal is expected to be EPS accretive and funded via a mix of equity (₹475 Cr) and debt (₹745 Cr + ₹800 Cr loan facility). This is a transformative, high-conviction bet on fermentation capabilities and global expansion.

  • Sky Gold & Diamonds (BULLISH)
    ▲

    Acquiring 100% of Purvi Gems for ₹9 Cr. Purvi's revenue grew 30% YoY to ₹103.4 Cr (FY26) from ₹78.95 Cr (FY25), and 52% from ₹67.87 Cr (FY24). The acquisition price is just 8.7% of FY26 revenue, suggesting a highly attractive valuation for a fast-growing gems & jewellery player.

  • Acme Solar Holdings ↓ (MIXED)
    ▲

    Merging three wholly-owned subsidiaries (Pokhran Solar, Sikar Solar, Eco Clean) into itself. The move is exempt from related-party compliance and involves no cash/share consideration. While simplifying structure, two of the three transferor companies reported net losses, indicating the merger may be a cleanup of non-performing entities.

  • Sodhani Academy of Fintech Enablers ↓ (NEUTRAL)
    ▲

    Acquired a 1% stake in CredArc Technologies (ESG tech) for ₹1 Cr. CredArc was incorporated just 3 months ago (June 2026) and has zero turnover. The investment is a tiny, speculative bet on the digital compliance space, with no insider activity to suggest management conviction.

  • Ashika Credit Capital (now Ashika Global Securities) (BULLISH)
    ▲

    Incorporated two wholly-owned subsidiaries (AMC and Trustee) with a combined authorized capital of ₹60.1 Cr. This is a major pivot into the mutual fund business, pending SEBI approval. The scale of capital commitment (₹60 Cr for AMC) signals serious intent, but execution risk is high.

  • Meghna Infracon Infrastructure ↓ (NEUTRAL)
    ▲

    Promoter Vikram Lodha bought 10,000 shares from the open market at ₹687.99/share (total ₹68.8 Lakhs). This is a routine insider acquisition (0.046% of equity) and does not indicate a broader M&A trend.

  • Zim Laboratories ↓ (NEUTRAL)
    ▲

    Incorporated a wholly-owned subsidiary in Chile (ZIM Laboratories SpA) for ~₹1.4 Cr. This is a low-cost entry into the LATAM pharma market. No regulatory approvals were needed, suggesting a quick, low-risk expansion.

  • Welspun Corp ↓ (NEUTRAL)
    ▲

    Approved incorporation of a step-down subsidiary in Jordan (Welspun Pipe Jordan) for manufacturing tubular products. This is a strategic move to expand Middle East manufacturing capacity, likely to serve oil & gas demand. No financial details disclosed.

  • Indoco Remedies ↓ (NEUTRAL)
    ▲

    Approved incorporation of a wholly-owned subsidiary (Warren Lifesciences) with a nominal capital of ₹1 Lakh. The entity will manufacture APIs and formulations. This is a small, early-stage move with no financial impact yet.

  • Oneindig Technologies ↓ (NEUTRAL)
    ▲

    Acquired a commercial office in Faridabad for ₹2 Cr (funded via internal accruals). The transaction is a routine asset purchase for business expansion, not a transformative M&A.

Risk Flags (9)

  • Gujarat Themis Biosyn / Leverage Risk↓ [HIGH RISK]
    ▼

    The MBJ acquisition is fully debt/equity financed (₹745 Cr loan + up to ₹800 Cr additional loan facility). This could significantly increase the company's debt-to-equity ratio. Investors should monitor Q2 FY27 filings for post-acquisition leverage metrics.

  • Acme Solar Holdings / Subsidiary Losses↓ [MEDIUM RISK]
    ▼

    Two of the three merging subsidiaries (ACME Pokhran Solar, ACME Sikar Solar, ACME Eco Clean) reported net losses. The merger may be a mechanism to absorb these losses into the parent, potentially diluting near-term profitability.

  • Sodhani Academy / Speculative Investment↓ [HIGH RISK]
    ▼

    The ₹1 Cr investment in CredArc Technologies (incorporated June 2026, zero turnover) is a high-risk, early-stage bet. There is no track record, no insider buying, and the 1% stake provides negligible control or influence.

  • Ashika Global Securities / Regulatory Hurdle [MEDIUM RISK]
    ▼

    The incorporation of the AMC and Trustee subsidiaries is contingent on SEBI approval. Any delay or denial of the mutual fund license would render the ₹60 Cr capital commitment stranded.

  • Indoco Remedies / New Entity Risk↓ [LOW RISK]
    ▼

    Warren Lifesciences is yet to be incorporated. There is no financial data, no operational history, and no timeline for commencement. The ₹1 Lakh capital is trivial, but the risk of execution delays is real.

  • Welspun Corp / Geopolitical Risk↓ [MEDIUM RISK]
    ▼

    The new subsidiary in Jordan exposes Welspun to Middle East geopolitical risks, including supply chain disruptions, regulatory changes, and currency volatility.

  • Zim Laboratories / Small-Scale Expansion↓ [LOW RISK]
    ▼

    The Chile subsidiary is capitalized at just ₹1.4 Cr. This is a very small bet on LATAM expansion and may not move the needle for the company. Investors should watch for further capital infusion.

  • Oneindig Technologies / Asset Quality↓ [LOW RISK]
    ▼

    The ₹2 Cr commercial property in Faridabad is a single-asset purchase. There is no disclosure of the property's valuation or rental yield, making it difficult to assess the strategic rationale.

  • Meghna Infracon / Low Materiality↓ [LOW RISK]
    ▼

    The promoter's share purchase of 0.046% equity is negligible. It does not signal a change in control or a broader M&A strategy.

Opportunities (8)

  • Sky Gold & Diamonds / High-Growth Bolt-On (OPPORTUNITY)
    ◆

    Acquiring Purvi Gems at ~8.7% of FY26 revenue (₹9 Cr for a ₹103.4 Cr revenue company) is a highly accretive deal. Purvi's 30% YoY revenue growth suggests strong brand equity and market share gains. Investors should watch for post-acquisition margin expansion and cross-selling synergies.

  • Gujarat Themis Biosyn / EPS Accretion & Global Scale↓ (OPPORTUNITY)
    ◆

    The MBJ acquisition (JPY 9.5B revenue, 60+ years of experience) is expected to be EPS accretive. The deal gives GTBL a strong foothold in Japan and the broader Asian pharma market. If integration is smooth, the stock could re-rate higher.

  • Ashika Global Securities / Mutual Fund Foray (OPPORTUNITY)
    ◆

    The incorporation of an AMC with ₹60 Cr capital is a bold move into the fast-growing Indian mutual fund industry. If SEBI approval is obtained, Ashika could capture a niche in the SME or alternative investment space.

  • Acme Solar Holdings / Simplification & Cost Savings↓ (OPPORTUNITY)
    ◆

    The merger of three wholly-owned subsidiaries will simplify the group structure and likely reduce compliance and administrative costs. While two subsidiaries are loss-making, the consolidation could lead to better capital allocation and tax efficiencies.

  • Zim Laboratories / LATAM Pharma Gateway↓ (OPPORTUNITY)
    ◆

    The Chile subsidiary provides a low-cost entry point into the LATAM pharmaceutical market. Chile has a stable regulatory environment and growing demand for generic drugs. If Zim scales up operations, this could become a meaningful revenue driver.

  • Welspun Corp / Middle East Manufacturing Hub↓ (OPPORTUNITY)
    ◆

    The Jordan subsidiary positions Welspun to serve the growing oil & gas pipeline demand in the Middle East. Jordan offers competitive manufacturing costs and proximity to key markets.

  • Oneindig Technologies / Real Estate Asset Play↓ (OPPORTUNITY)
    ◆

    The ₹2 Cr office property in Faridabad's IT Park could appreciate in value and provide long-term operational benefits. The use of internal accruals (no debt) is a positive sign of financial discipline.

  • Indoco Remedies / API & Formulation Expansion↓ (OPPORTUNITY)
    ◆

    The new subsidiary (Warren Lifesciences) will manufacture APIs and finished formulations, aligning with the government's PLI scheme for pharma. If executed well, this could boost Indoco's vertical integration and margins.

Sector Themes (6)

  • Specialty Pharma & Biotech Consolidation (HIGH IMPACT)
    ◆

    Gujarat Themis Biosyn's large-scale acquisition of MicroBiopharm Japan (₹1,220+ Cr) and Zim Laboratories' LATAM expansion highlight a trend of Indian pharma companies seeking global scale through M&A. The focus is on high-margin fermentation and specialty products.

  • Gems & Jewellery: Bolt-On Acquisitions at Attractive Valuations (MEDIUM IMPACT)
    ◆

    Sky Gold & Diamonds' acquisition of Purvi Gems at ~8.7% of revenue is a classic example of a larger player buying a high-growth, profitable smaller firm at a reasonable price. This could signal a wave of consolidation in the fragmented jewellery sector.

  • Renewable Energy: Corporate Simplification (MEDIUM IMPACT)
    ◆

    Acme Solar's merger of three wholly-owned subsidiaries (including two loss-making ones) reflects a broader trend in the renewable sector of streamlining complex holding structures to improve transparency and reduce costs.

  • Financial Services: New Entrants in Asset Management (MEDIUM IMPACT)
    ◆

    Ashika Global Securities' incorporation of an AMC with ₹60 Cr capital is a significant bet on the mutual fund industry. This suggests that smaller financial firms see an opportunity to disrupt the market with niche or SME-focused funds.

  • Infrastructure & Manufacturing: Geographic Diversification (LOW IMPACT)
    ◆

    Welspun Corp's Jordan subsidiary and Oneindig Technologies' Faridabad office purchase show a dual trend: Indian companies are expanding manufacturing bases in geopolitically stable regions (Middle East) while also investing in domestic real estate for operational needs.

  • ESG & Fintech: Early-Stage Speculation (LOW IMPACT)
    ◆

    Sodhani Academy's ₹1 Cr investment in a 3-month-old ESG tech startup (CredArc) with zero revenue is a micro-trend of Indian companies making small, speculative bets on emerging themes. This is high-risk, high-reward and should be monitored for follow-on investments.

Watch List (8)

  • Gujarat Themis Biosyn↓
    👁

    Post-acquisition leverage metrics and integration progress. Watch Q2 FY27 filings for debt-to-equity ratio and MBJ's revenue contribution. [Date: Q2 FY27 results, likely Nov 2026]

  • Sky Gold & Diamonds
    👁

    Completion of Purvi Gems acquisition (expected by Nov 30, 2026). Watch for post-acquisition revenue and margin synergies. [Date: Nov 30, 2026]

  • Ashika Global Securities
    👁

    SEBI approval for the mutual fund AMC. Any regulatory delay could impact the ₹60 Cr capital deployment. [Date: Ongoing, no specific deadline]

  • Acme Solar Holdings↓
    👁

    NCLT approval for the scheme of amalgamation. Watch for any objections from creditors or minority shareholders. [Date: Unknown, typically 3-6 months]

  • Welspun Corp↓
    👁

    Incorporation of Jordan subsidiary and any subsequent orders from Middle East oil & gas companies. [Date: Unknown]

  • Zim Laboratories↓
    👁

    First operational update from the Chile subsidiary. Watch for any further capital infusion or partnership announcements. [Date: Unknown]

  • Sodhani Academy↓
    👁

    Any follow-on investment in CredArc Technologies or other ESG tech startups. A larger investment would signal higher conviction. [Date: Unknown]

  • Meghna Infracon↓
    👁

    Promoter's future share purchases. If the buying pattern continues, it could signal a re-rating or a potential delisting offer. [Date: Ongoing]

Filing Analyses (11)
Acme Solar Holdings Limited Merger/Acquisition mixed materiality 6/10

18-09-2026

Acme Solar Holdings Limited (ACMESOLAR) announced a Scheme of Amalgamation to merge three wholly owned subsidiaries—ACME Pokhran Solar Private Limited, ACME Sikar Solar Private Limited, and ACME Eco Clean Energy Private Limited—into itself. The merger is a related-party transaction but exempt from certain compliance requirements, and no cash or share consideration will be issued as the subsidiaries are wholly owned. The rationale includes simplifying the group structure, achieving cost savings, and strengthening the company's infrastructure business, though the transferor companies show mixed financial performance with two reporting net losses.

  • · The board meeting commenced at 6:52 PM IST and concluded at 7:09 PM IST on September 18, 2026.
  • · The scheme is exempt from compliance with Section 188 of the Companies Act, 2013 per MCA General Circular No. 30/2014 dated July 17, 2014.
  • · The scheme is exempt from Regulation 23(2), (3) and (4) of SEBI Listing Regulations per Regulation 23(5)(b).
  • · No change in shareholding pattern of the listed entity will occur.
  • · Two of the three transferor companies (ACME Pokhran Solar and ACME Eco Clean Energy) reported net losses as of March 31, 2026.
Sodhani Academy of Fintech Enablers Limited Merger/Acquisition neutral materiality 4/10

18-09-2026

Sodhani Academy of Fintech Enablers Limited completed the acquisition of a 1% stake in CredArc Technologies Private Limited for a cash consideration of ₹1,00,00,000 (₹1 Crore). The target company, incorporated on June 20, 2026, operates in the ESG technology and sustainability compliance solutions space and has no prior turnover. This strategic investment is intended to give Sodhani exposure to the growing digital compliance and reporting ecosystem.

  • · The acquisition was approved by the Board on September 09, 2026, and completed on September 18, 2026.
  • · The transaction is not classified as a related party transaction; none of the promoter/promoter group/group companies have any interest in CredArc Technologies.
  • · CredArc Technologies Private Limited was incorporated on June 20, 2026, and has no turnover history.
  • · The acquisition is a cash consideration transaction, not a share swap.
Oneindig Technologies Ltd Merger/Acquisition positive materiality 5/10

18-09-2026

Oneindig Technologies Ltd has acquired a commercial office space in Faridabad, Haryana for a total consideration of ₹2.00 Crore, funded through internal accruals. The transaction was closed on September 18, 2026, and is intended to support the company's business expansion and long-term strategic requirements. The seller, Dove Infrastructure Private Limited, is not a related party, and the transaction does not involve any related party elements.

  • · The property is located at 1st Floor, Phase-1, Tower B (FBD One) IT Park, Sector-37, Faridabad, Haryana.
  • · The seller obtained all requisite approvals from concerned authorities.
  • · The transaction exceeds the materiality threshold under Regulation 30(4) of SEBI LODR Regulations.
  • · The purchase consideration was arrived at on an arm's-length basis.
  • · No adverse impact on the company's operations was noted.
Indoco Remedies Limited Merger/Acquisition neutral materiality 3/10

18-09-2026

Indoco Remedies Limited has approved the incorporation of a wholly owned subsidiary, Warren Lifesciences Private Limited, to manufacture and sell pharmaceutical products including APIs and finished formulations. The subsidiary will be capitalized at ₹1,00,000 (10,000 equity shares of ₹10 each) and will be 100% held by Indoco. No financial performance data is available as the entity is yet to be incorporated.

  • · The subsidiary will be incorporated in India and is subject to approval from the Registrar of Companies / Ministry of Corporate Affairs.
  • · Consideration for subscription is cash at face value of ₹10 per share.
  • · 100% shareholding will be held by Indoco Remedies Limited.
Welspun Corp Limited Merger/Acquisition neutral materiality 3/10

18-09-2026

Welspun Corp Limited (WCL) announced that its wholly-owned subsidiary, Welspun Global Holdings Limited (WGHL), has approved the incorporation of a wholly owned subsidiary in Jordan. The new entity, to be named 'Welspun Pipe Jordan, PSC' or similar, will manufacture iron and steel tubular products including line pipes for oil, gas, and water transportation. Upon incorporation, it will become a step-down wholly owned subsidiary of WCL, with 100% shareholding by WGHL via cash consideration.

  • · The new subsidiary will be incorporated in Jordan.
  • · The subsidiary's business includes manufacturing, producing, processing, and fabricating wires, tubes, and pipes of iron and steel.
  • · The incorporation is subject to approval from Jordanian statutory authorities.
  • · The consideration for subscription of shares will be in cash.
  • · The exact date of incorporation and cost of subscription will be provided later.
SKY GOLD AND DIAMONDS LIMITED Merger/Acquisition positive materiality 8/10

18-09-2026

Sky Gold and Diamonds Limited has approved the acquisition of 100% of Purvi Gems & Jewellery (India) Private Limited for a cash consideration of up to ₹9,00,00,000 (₹9 Crore). The target company reported a turnover of approximately ₹103.40 Crore for FY 2025-26, up from ₹78.95 Crore in FY 2024-25 and ₹67.87 Crore in FY 2023-24, indicating strong growth. The acquisition is expected to be completed by November 30, 2026, and aims to expand Sky Gold's product portfolio and market share in the gems and jewellery segment.

  • · The acquisition is not a related party transaction and the promoter/promoter group has no interest in the target entity.
  • · The target company was incorporated on December 3, 2010.
  • · The Board meeting lasted from 8:40 AM IST to 8:55 AM IST on September 18, 2026.
  • · The acquisition is expected to be completed on or before November 30, 2026.
Zim Laboratories Limited Merger/Acquisition neutral materiality 4/10

18-09-2026

Zim Laboratories Limited has incorporated a wholly owned subsidiary, ZIM Laboratories SpA, in Santiago, Chile, as part of its expansion into the LATAM pharmaceutical market. The subsidiary was incorporated on September 9, 2026, with the holding company subscribing to 14,100 shares at CLP 1,000 each for a total cash consideration of CLP 14,100,000 (approximately ₹1.4 Cr). No governmental or regulatory approvals were required for this incorporation.

  • · The subsidiary was incorporated on September 9, 2026, in Santiago, Republic of Chile.
  • · The holding company subscribed to 14,100 shares at a face value of CLP 1,000 each, representing 100% shareholding.
  • · No governmental or regulatory approvals were required for the acquisition.
  • · The consideration was in cash (not share swap).
SKY GOLD AND DIAMONDS LIMITED Merger/Acquisition positive materiality 8/10

18-09-2026

Sky Gold and Diamonds Limited has approved the acquisition of 100% of Purvi Gems & Jewellery (India) Private Limited for a cash consideration of up to ₹9,00,00,000 (₹9 Crore). The target company reported a turnover of approximately ₹103.40 Crore for FY 2025-26, up from ₹78.95 Crore in FY 2024-25 and ₹67.87 Crore in FY 2023-24, showing strong growth. The acquisition is expected to be completed on or before 30th November 2026.

  • · The acquisition does not fall within related party transaction purview.
  • · Target company was incorporated on 03/12/2010.
  • · Board meeting commenced at 8:40 AM IST and concluded at 8:55 AM IST on 18th September 2026.
  • · The company was formerly known as Sky Gold Limited.
Gujarat Themis Biosyn Limited Merger/Acquisition positive materiality 9/10

18-09-2026

Gujarat Themis Biosyn Limited (GTBL) completed the acquisition of 100% of MicroBiopharm Japan Co., Ltd. (MBJ) through its wholly owned subsidiary Themis Biosyn Japan Limited (TBJ). The total consideration was JPY 21.5 billion, funded via an investment of INR 475 Crores as capital contribution and INR 745 Crores as a loan in TBJ, with an additional loan agreement of up to INR 800 Crores. The acquisition is expected to be EPS accretive and expands GTBL's fermentation capabilities, product portfolio, and global footprint; however, no financial performance metrics for GTBL itself are disclosed, and the acquisition is fully debt/equity financed, which may increase leverage.

  • · MBJ generated revenue of JPY 9.5 billion for FY26.
  • · The acquisition was first announced on May 22, 2026.
  • · MBJ has over 60 years of experience.
  • · The existing MBJ management team will continue to lead operations.
  • · The loan agreement is between GTBL and its wholly owned subsidiary and is not a related party transaction.
  • · GTBL's India manufacturing scale is expected to improve cost competitiveness and drive margin expansion on high-value products.
  • · Advisors: Deloitte India (financial advisor), Tokyo International Law Office (legal counsel), Avendus Capital (financing arranger).
Ashika Credit Capital Ltd. Merger/Acquisition neutral materiality 5/10

18-09-2026

Ashika Global Securities Limited (formerly Ashika Credit Capital Ltd) has incorporated two wholly-owned subsidiaries on September 17, 2026: Ashika Global Asset Management Private Limited (AGAMPL) and Ashika Global Trustee Company Private Limited (AGTCPL). AGAMPL, with an authorized and paid-up capital of ₹60,00,00,000 (60 Crore), will act as an Asset Management Company for mutual fund schemes, while AGTCPL, with a capital of ₹10,00,000 (10 Lakh), will serve as a trustee for pooled investment vehicles. Both entities are newly incorporated with nil turnover and are yet to commence operations, pending regulatory approvals from SEBI.

  • · The company name changed from Ashika Credit Capital Limited to Ashika Global Securities Limited (CIN: L67120WB1994PLC062159).
  • · AGAMPL has CIN U66301MH2026PTC475827 and AGTCPL has CIN U66190MH2026PTC475817, both incorporated under the Companies Act, 2013.
  • · Both subsidiaries have their registered office in Maharashtra.
  • · The sponsor had received necessary approval from SEBI for incorporation of both companies, but commencement of activities is subject to further SEBI approval.
  • · The acquisition is a cash consideration for 100% subscription to the share capital of each WOS.
  • · The filing is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meghna Infracon Infrastructure Limited Merger/Acquisition neutral materiality 2/10

18-09-2026

Meghna Infracon Infrastructure Limited disclosed that promoter Mr. Vikram Jayantilal Lodha acquired 10,000 equity shares from the open market on September 17, 2026, at a total value of ₹68,79,900 (₹687.99 per share), representing 0.046% of total shareholding. The transaction is a routine insider acquisition and does not involve any merger or acquisition of a company or business.

Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 11 filings

Start free trial Browse all digests

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India Merger Acquisition MCA Regulatory Filings

September 09, 2026

India Merger Acquisition MCA Regulatory Filings — September 09, 2026

September 08, 2026

India Merger Acquisition MCA Regulatory Filings — September 08, 2026

September 07, 2026

India Merger Acquisition MCA Regulatory Filings — September 07, 2026

September 06, 2026

India Merger Acquisition MCA Regulatory Filings — September 06, 2026

🇮🇳 More from India

View all →

September 11, 2026

India Pre-Market Regulatory Roundup — September 11, 2026

India Pre-Market Regulatory Roundup

September 11, 2026

India Quarterly Results BSE NSE Announcements — September 11, 2026

India Quarterly Results BSE NSE Announcements

September 11, 2026

India Upcoming Corporate Actions BSE NSE — September 11, 2026

India Upcoming Corporate Actions BSE NSE

September 10, 2026

India Upcoming Corporate Actions BSE NSE — September 10, 2026

India Upcoming Corporate Actions BSE NSE
← All India digests